13-23889163-CCCTGGGGCTTGA-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PM4
The NM_005932.4(MIPEP):c.146_157delTCAAGCCCCAGG(p.Val49_Gln52del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.000000761 in 1,313,938 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 7.6e-7 ( 0 hom. )
Consequence
MIPEP
NM_005932.4 disruptive_inframe_deletion
NM_005932.4 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.58
Genes affected
MIPEP (HGNC:7104): (mitochondrial intermediate peptidase) The product of this gene performs the final step in processing a specific class of nuclear-encoded proteins targeted to the mitochondrial matrix or inner membrane. This protein is primarily involved in the maturation of oxidative phosphorylation (OXPHOS)-related proteins. This gene may contribute to the functional effects of frataxin deficiency and the clinical manifestations of Friedreich ataxia. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in NM_005932.4.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MIPEP | ENST00000382172.4 | c.146_157delTCAAGCCCCAGG | p.Val49_Gln52del | disruptive_inframe_deletion | 1/19 | 1 | NM_005932.4 | ENSP00000371607.3 | ||
PCOTH | ENST00000382133.9 | n.170+154_170+165delCTGGGGCTTGAC | intron_variant | 1 | ||||||
MIPEP | ENST00000469167.1 | n.224_235delTCAAGCCCCAGG | non_coding_transcript_exon_variant | 1/3 | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 7.61e-7 AC: 1AN: 1313938Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 646166
GnomAD4 exome
AF:
AC:
1
AN:
1313938
Hom.:
AF XY:
AC XY:
0
AN XY:
646166
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 25, 2022 | The c.146_157del12 (p.V49_Q52del) alteration is located in exon 1 (coding exon 1) of the MIPEP gene. This alteration consists of an in-frame deletion of 12 nucleotides between nucleotide positions c.146 and c.157, resulting in the deletion of <NA> residues. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at